R. Andrew Ramelmeier
2019
Compensation breakdown
| Non-Equity Incentive Plan | $153,608 |
|---|---|
| Option Awards | $449,453 |
| Salary | $382,965 |
| Stock Awards | $112,875 |
| Other | $5,639 |
| Total | $1,104,540 |
Ramelmeier received $449.5K in option awards, accounting for 41% of the total pay in 2019.
Ramelmeier also received $153.6K in non-equity incentive plan, $383K in salary, $112.9K in stock awards and $5.6K in other compensation.
Rankings
In 2019, R. Andrew Ramelmeier's compensation ranked 8,820th out of 13,971 executives tracked by ExecPay. In other words, Ramelmeier earned more than 36.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,820 out of 13,971 | 37th |
Division Manufacturing | 3,514 out of 5,701 | 38th |
Major group Chemicals And Allied Products | 1,327 out of 2,200 | 40th |
Industry group Drugs | 1,129 out of 1,886 | 40th |
Industry Biological Products, Except Diagnostic Substances | 253 out of 389 | 35th |
Pay ratio
| R. Andrew Ramelmeier's Pay | $1,104,540 |
|---|---|
| Median Employee's Pay | $159,900 |
| Pay Ratio | 7to 1 |
In 2019, the annual total compensation of R. Andrew Ramelmeier was $1,104,540.
The annual total compensation of the median employee at Sangamo Biosciences was $159,900.
The ratio of R. Andrew Ramelmeier's pay to the pay of median employee was therefore 7 to one.
Ramelmeier's colleagues
We found six more compensation records of executives who worked with R. Andrew Ramelmeier at Sangamo Biosciences in 2019.
2019
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2019
Sung Lee
Sangamo Biosciences
Chief Financial Officer
2019
Adrian Woolfson
Sangamo Biosciences
Executive Vice President, Research and Development
2019
Gary Loeb
Sangamo Biosciences
General Counsel
2019
Stéphane Boissel
Sangamo Biosciences
Chief Financial Officer
2019
Kathy Yi
Sangamo Biosciences